Last reviewed · How we verify

NCT06113497

A Prospective Study on the Comparison of Postoperative Pain According to the Use of Cocktail Therapy in Laminoplasty

Status unknown Phase 4 Last updated 14 November 2023
What this trial tests

Phase 4 trial testing Cocktail injection in Adverse Effects in the Therapeutic Use of Analgesic, Antipyretic and Anti-Inflammatory Drug, Unspecified in 60 participants. Status unknown.

Timeline
25 November 2023
Primary endpoint
24 October 2024
30 September 2025

Quick facts

Lead sponsorKyunghee University Medical Center
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingtriple
Primary purposesupportive care
Enrollment60
Start date25 November 2023
Primary completion24 October 2024
Estimated completion30 September 2025

Drugs / interventions tested

Conditions studied

Sponsor

Kyunghee University Medical Center

Who can join

Adults 20 to 80, any sex, with Adverse Effects in the Therapeutic Use of Analgesic, Antipyretic and Anti-Inflammatory Drug, Unspecified. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is the first prospective randomized controlled trial to analyze the effects and safety of multimodal cocktail injections after cervical laminoplasty

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effects of multimodal cocktail analgesic local injection in postoperative pain control after laminoplasty: A study protocol of a prospective randomized controlled trial.
    Soh J, Park HS, Lee WY, Park SH, et al · · 2025 · PMID 40512737 · DOI 10.1371/journal.pone.0324791

Verify or expand the search:

Other Kyunghee University Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06113497.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing